Life Conflux (ISSN: 3078-4816) is committed to promoting the publication of high-quality academic research. Manuscripts that present experimental data will qualify for a waiver of the article processing charges (APCs).
Overview
Why publish in Life Conflux?
- Fast decision times. 3 days to desk rejection, 23 days to first decision.
- Your research will be open access, resulting in more downloads, shares and cites.
- There’s no cost to you. Article publication fees are currently waived.
- Video submissions make it easier for readers to access and digest content.
- Open data and codes will help further advance our knowledge and research and drive impact in the field.
- Figures are polished for the highest quality publication.
Brief introduction
Life Conflux (ISSN: 3078-4816) is an open-access and Life Conflux Press partner journal launched by scientists. The journal aims to promote life science and bioinformatics development by publishing original researches, reproducible methods or protocols, and systematic reviews. The goal is to publish highly impactful papers with a wide range of readers, and to provide peers with novel findings, easy-to-use analysis tools, and systematic knowledge.
Unique Features
- Video submission: 3~5 min speech video to introduce your work
- Reproducible: analysis method with video tutorial
- Figure polishing: to ensure highest quality output
- Promotion by social media: WeChat, and Weibo with 500,000 followers in bioinformatics
- Open access: golden open access and 4500 USD / 3807 GBP / 4496 EUR APC waiver before 2026
- Publishing is the beginning: news promotion, translated version, and method updates (protocols, software, database, or scripts)
Scope
The Life Conflux is an international, peer-reviewed, open access journal that welcomes Review Article, Opinion, Perspective, Progress. Meta-analyses will no longer be considered for publication.
- Acute/chronic inflammation
- Mediators of inflammation
- Cellular processes
- Molecular mechanisms
- Neuroimmune mechanisms
- Pharmacology and novel anti-inflammatory drugs
- Clinical conditions involving inflammation
- Conditions covered include:
- Asthma and allergy
- Diabetes mellitus
- Heart disease and heart failure
- Skin conditions e.g. dermatitis, psoriasis, and dermatomyositis
- Joint conditions e.g. osteoarthritis, rheumatoid arthritis, gouty arthritis
- Spondylitis
- Pneumonia
- Neuroinflammation
- Sepsis
- Cancer
- Ulcerative colitis
- Crohn's disease
- Pancreatitis
- Inflammatory bowel disease
- Autoimmunity
- Antigen processing and presentation
- Apoptosis and cell death
- Chemokines and chemokine receptors
- Cytokines and cytokine receptors
- Development and function of cells of the immune system
- Haematopoiesis
- Infection and immunity
- Immunotherapy
- Innate immunity
- Mucosal immunology and the microbiota
- Regulation of the immune response
- Signalling in the immune system
- Transplantation
- Tumour immunology and immunotherapy
Future Indexing Information
- Biological Abstracts (Clarivate Analytics)
- BIOSIS (Clarivate Analytics)
- CAS: Chemical Abstracts Service (ACS)
- Current Contents: Life Sciences (Clarivate Analytics)
- Directory of Open Access Journals (DOAJ)
- PubMed (NLM)
- Science Citation Index Expanded (Clarivate Analytics)
- SCOPUS (Elsevier)
- Web of Science (Clarivate Analytics)
Life Conflux (ISSN: 3078-4816) will deposit all articles in PMC (PubMed Central)
Basic information
- Journal: Life Conflux
- Online ISSN: 3078-4816
- Publisher: Life Conflux Press Limited
- Peer review: Single-anonymous
- Publishing frequency: Quarterly
Sign up for email alerts
Enter your email to receive alerts when new articles and issues are published.
More from this journal
Access rights
Life Conflux is open access. All content is freely available to read, download and share immediately upon publication.
License
Life Conflux is licensed under a Creative Commons Attribution 4.0 International License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Copyright
Submission of a manuscript to the Life Conflux journal directly implies that all the authors have read and agreed to the journal's guidelines. The content present in the manuscript after publication will be freely available to all the potential readers over the Internet.
Notice
The content provided by the authors in the manuscript should at no point of time breach the Copyrights or rights of a third party. The manuscript submitted should not be published or submitted for consideration in any other journal. Manuscripts with plagiarized content will not be considered for the peer-review process.
DigitalObject Unique Identifier
DOI is registered through Crossref to ensure that each content has a unique identifier and supports citation statistics and long-term content preservation.
Recent issues
